| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/25/2005 | CN1618811A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/25/2005 | CN1618805A Nerve system development related protein and its coding sequence and use |
| 05/25/2005 | CN1618803A Recombinated phycobiliprotein and its preparation method and application |
| 05/25/2005 | CN1618789A Macrocyclic peptides active against the hepatitis C virus |
| 05/25/2005 | CN1618463A Composite prepns. for treating and preventing SARS |
| 05/25/2005 | CN1618462A Compositions of SOD and vetetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618461A Composition of nano-SOD and vegetative medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618460A Composition of SOD and animal medicine or its extractives, and its prepn. method |
| 05/25/2005 | CN1618459A Translation initiation factor eIF-5A and medical application of it and syntenin complex |
| 05/25/2005 | CN1618458A Novel dopaminergic neuron protective factor, and its application |
| 05/25/2005 | CN1618457A Method for preparing prepn. of immune modulation factor |
| 05/25/2005 | CN1203182C Gene engineering body for somatostatin gene engineering subunit seedling |
| 05/25/2005 | CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis |
| 05/25/2005 | CN1203179C DNA sequence and recombination production method of graminae allergen |
| 05/25/2005 | CN1203178C Multivalent antigen-binding proteins |
| 05/25/2005 | CN1203177C Tumor antigen proteins, genes thereof and tumor antigen peptides |
| 05/25/2005 | CN1203091C TGF (b) 1 inhibitor peptides |
| 05/25/2005 | CN1203090C Cyclic bonding inhibitor |
| 05/25/2005 | CN1203089C New compound |
| 05/25/2005 | CN1203087C Factor VIIa inhibitors |
| 05/25/2005 | CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 05/25/2005 | CN1202862C Compsns. comprising comjugates of stable, active, human OB protein with antibody Fc chain and methods |
| 05/25/2005 | CN1202861C Use of compound interferon in treating SARS disease |
| 05/25/2005 | CN1202860C Anti-SARS virus transfer factor preparation method |
| 05/25/2005 | CA2448831A1 Multi-stage cascade boosting vaccine |
| 05/24/2005 | US6897306 3-heterocyclylpropanohydroxamic acids |
| 05/24/2005 | US6897297 Hydrophobically-modified protein compositions and methods |
| 05/24/2005 | US6897296 Antibody that specifically binds an Mch5 polypeptide |
| 05/24/2005 | US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2005 | US6897293 A DNA sequence encoding a gax protein or portion, which inhibits vascular smooth muscle cell proliferation, useful in the treatment of blood vessel diseases |
| 05/24/2005 | US6897292 For detecting a genetic abnormality, cancer |
| 05/24/2005 | US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/24/2005 | US6897288 Mage-A12 antigenic peptides and uses thereof |
| 05/24/2005 | US6897287 Ro/SSA peptide reagents for diagnosis of autoantibodies |
| 05/24/2005 | US6897286 Polypeptide for use in the treatment of gastrointestinal disorders |
| 05/24/2005 | US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives |
| 05/24/2005 | US6897197 Method of inhibiting cell proliferation using an anti-oncogene protein |
| 05/24/2005 | US6897069 System and method for electroporating a sample |
| 05/24/2005 | US6897062 For diagnosis/therapy of cancer/tumors in vitro; refractories |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6897052 N-acetylglycosaminyl transferase genes |
| 05/24/2005 | US6897050 Desaturase genes and their use |
| 05/24/2005 | US6897049 Industrial/pharmaceutical/commercial production of hyper/hypo allergenic compositions; proteases |
| 05/24/2005 | US6897043 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering |
| 05/24/2005 | US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in |
| 05/24/2005 | US6897029 For drug screening anticancer agents; genetic engineering; differential isoform splicing |
| 05/24/2005 | US6897016 For therapy of diseases using ribozymes; splicing/genetic engineering; chimeric nucleic acids/proteins |
| 05/24/2005 | US6896906 A spray dried powder prepared by aerosolization; superior chemical and physical stability over their solution counterparts; inhaleable powder |
| 05/24/2005 | US6896904 Multilayer crosslinking porous structure; prosthetic bones, drug delivery |
| 05/24/2005 | US6896899 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 05/24/2005 | US6896887 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium |
| 05/24/2005 | US6896886 Administering neurotoxins; analgesics; antisecretory agent |
| 05/24/2005 | US6896885 Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 05/24/2005 | US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/24/2005 | US6896880 Interleukins; osteoporosis therapy |
| 05/24/2005 | US6896879 Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture |
| 05/24/2005 | CA2307655C Tolerogenic fragments of natural allergens |
| 05/24/2005 | CA2214889C Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof |
| 05/24/2005 | CA2200935C Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 05/24/2005 | CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists |
| 05/24/2005 | CA2151476C Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 05/24/2005 | CA2109259C Prodrugs, their preparation and use as pharmaceuticals |
| 05/24/2005 | CA2037607C Humanised antibodies |
| 05/24/2005 | CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 05/20/2005 | CA2487657A1 Specific markers for metabolic syndrome |
| 05/20/2005 | CA2450297A1 Method for preventing mineralization in the periodontal ligament (pdl) |
| 05/19/2005 | WO2005045428A2 Methods and compositions for modulating apoptosis |
| 05/19/2005 | WO2005045055A2 The use of plp with peg-rmetase in vivo for enhanced efficacy |
| 05/19/2005 | WO2005045041A2 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005045040A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /siNA) |
| 05/19/2005 | WO2005045039A2 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045038A2 RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045037A2 RNA INTERFERENCE MEDIATED INHIBITION OF 5-ALPHA REDUCTASE AND ANDROGEN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045035A2 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045032A2 RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/19/2005 | WO2005045027A1 Wt1-origin hla-dr-binding antigen peptide |
| 05/19/2005 | WO2005044993A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 05/19/2005 | WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same |
| 05/19/2005 | WO2005044984A2 Modulators of the abc transporter family and methods for their use |
| 05/19/2005 | WO2005044982A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 05/19/2005 | WO2005044981A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005044854A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 05/19/2005 | WO2005044851A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 05/19/2005 | WO2005044850A1 Helical protein zcyto32 |
| 05/19/2005 | WO2005044847A1 Marker peptide for alzheimer’s disease |
| 05/19/2005 | WO2005044845A2 Protein binding miniature proteins |
| 05/19/2005 | WO2005044844A2 Protozoan strains of reduced virulence and use thereof |
| 05/19/2005 | WO2005044842A1 Peptide useful for diagnosis and therapy of tumors |
| 05/19/2005 | WO2005044839A2 Stabilized alpha helical peptides and uses thereof |
| 05/19/2005 | WO2005044325A1 Composite material containing hydrogen, produced by the electrically-triggered precipitation of a solid phase |
| 05/19/2005 | WO2005044313A2 Conjugates of angiotensin ii and an imaging moiety |
| 05/19/2005 | WO2005044309A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 05/19/2005 | WO2005044306A2 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 05/19/2005 | WO2005044298A1 Compositions and methods of treatment |
| 05/19/2005 | WO2005044297A1 Use of interferon-tau in medecine |
| 05/19/2005 | WO2005044296A1 G-csf therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| 05/19/2005 | WO2005044295A1 Use of gh secretagogues in hypoxic-ischemic brain injury |
| 05/19/2005 | WO2005044294A2 Method of therapy for cancers expressing the cd40 antigen |